text:
Ксантоцерас, или Чекалкин орех () — монотипный род листопадных деревья, входящий в семейство . Единственный вид — Ксантоцерас рябинолистный (Xanthoceras sorbifolium).

Распространение и экология
В диком виде произрастает в Северном Китае и Северной Корее. В культуре распространён на юге и западе Украины, в европейской части России, Крыму, Молдавии, Грузии, Азербайджане, Средней Азии.

Размножают посевом стратифицированных семян и корневыми черенками.

Ботаническое описание
Листопадное дерево высотой до 8 м с плотной пирамидальной кроной. Ветви довольно толстые, прямостоящие, в молодости мягковолосистые.

Листья очерёдные, без прилистников, непарноперистые, с 9—17 листочками, длиной 20—25 см. Листочки сидячие, обычно супротивные, иногда очерёдные, ланцетные, длиной 3—5 см, шириной 0,7—1,2 см, остропильчатые, кожистые, сверху тёмно-зелёные, снизу светлые.

Соцветие — густая, многоцветковая кисть, длиной 15—25 см, расположены на концах побегов и укороченных боковых веточках. Цветки белые, правильные, обоеполые и тычиночные, диаметром до 4 см, на цветоножках длиной около 1,5 см; чашелистиков 5, продолговатые, длиной 6—7 мм; лепестков 5, обратнояйцевидные, длиной 2 см, шириной 8 мм; тычинок 8; завязь 3-гнездная; рыльце головчато-трёхраздельное.

Плод — треугольно-яйцевидная или эллиптическая коробочка, диаметром до 5 см. Семена длиной до 1,8 см, диаметром 1,5 см, съедобные.

Значение и применение
Одно из красивейших декоративных растений, ценное обильным цветением и красивой яркой зеленью, сохраняющейся до поздней осени.

Литература

Примечания

Ссылки

Сапиндовые
Флора Азии
Декоративные деревья
Монотипные роды растений

redpajama_set_name: RedPajamaWikipedia


This is a list of impounds by city. If you have found a dog and don't know what to do with him, this is a good place to start contacting for help. Alternatively if you have lost a dog, this is a great place to start calling to see if they have picked up your dog.
Click on the first letter of your city to find your local impound information.
If your impound is not currently listed with us or your contact information is not correct please fill out our LDMN Shelter/Rescues/Impound Form with the appropriate information from your official email address associated with your impound, please include contact information and we will confirm and update this record.
Please select the first letter of the city you are looking for, to get the impound information.


text:
De Brontoscorpio is een uitgestorven schorpioen.

Hij leefde in het Siluur, was ongeveer een meter lang en mogelijk de voorouder van de Gigantoscorpio. Brontoschorpio at vissen en trilobieten en had geen zwemstaart zoals zijn (tijd)verwant Eurypterus.

De naam betekent donderschorpioen: bronto is donder, scorpio is schorpioen.

Ook op het land
Brontoscorpio is waarschijnlijk een van de eerste dieren die ook op het land voortbewoog. Eerder dus dan 'onze' voorouders. Het exoskelet van deze wezens was waarschijnlijk bestand tegen de felle zon en de hitte op het droge land, iets waartegen andere organismen nog niet beschermd waren.
In de documentaire "Seamonsters", wordt gesuggereerd dat de dieren aan land ook aangespoelde resten van dieren opaten en aan de kustlijn hun eitjes legden. Dit deden zij dan bij springvloed in de modder. De eitjes waren hier dan veilig voor de vele levensvormen die op dat moment op de aarde aanwezig waren. Er waren immers geen andere dieren op het land. De eitjes zouden dan later uitkomen als het weer springtij was zodat de jonge dieren terug konden naar de zee.

Zeeschorpioenen
Siluur


I just read some awful diatribe about how the West and Islam can never co-exist peacefully. Horsefeathers, I say. They can coexist just fine. We just have to do our due diligence in telling the difference between immigrant assimilation issues, geopolitically-fueled crimes, intolerant views held by a minority, and actual clashes of civilization.
I want to look first at the notion of Muslims somehow being less tolerant of other faiths than those other faiths are of Islam. In Spain in 1492, the rulers there began a set of policies that would eject Muslims and Jews from Spain. Hardly a symbol of Western tolerance – and it was Muslim nations, such as the Ottoman Empire, that welcomed in the Jewish population. The Jewish track record in the West pretty much stinks, really, what with ghettos and the whole Holocaust thing. Christian denominations within Western nations didn't fare so well, either. Protestants, Reformed, and Catholics alike committed massacres of the pacifist Anabaptists during the religious upheavals of the 16th and 17th Centuries. My own ancestors fled the United States in the 1840s and again in the 1890s because of religious persecution. They were Christian, but the USA seemed determined to deny them a right to practice their faith as they saw fit to do so.
And lest this become some argument for atheism, let me level the intellectual cannons at that lot. Atheism in the West is simply intolerant of all faiths and, like the religions they criticize, will cannibalize its own dissenters if they don't hold fast to a consensus view. Atheism in the West is not a movement that liberates people from group-think: it rather introduces a new paradigm for rejecting others based upon a set of beliefs. They're no better than any other group that uses a supposed proof to justify persecution of anyone that does not agree with said proof.
No, the true salvation from religious intolerance is to practice a mature faith that realizes each person is free to make choices, even choices that disappoint us. We must practice a mature faith that allows for others to find their own ways. We must practice a mature faith that seeks to find out what common ground we have with others, and not to discover fighting grounds.
I, a Christian, walked through a mosque and a Hindu mandir with a Muslim and a Hindu at my side through both experiences. I felt the faith being expressed in both locations. I have visited the places of worship of other Christian denominations and have been moved by their expressions of faith. Though I may not worship in the same way, do I not seek the same peace that they all seek? In our devotions, we are taught the need to love others and to strive to bless their lives through our deeds. The same is taught in the Quran, though it may deny Jesus' divinity. The same is taught in the Bhagavad-Gita, thought it may not have arisen out of the Southwest Asian monotheistic traditions. There is much more in our faiths that is alike than that which is different.
History shows that man can be cruel, but history also shows that man can be compassionate. It all depends upon our choices.
So, wherefore the existence of these conflicts? How to explain the terrorism and the lack of integration of Muslims into European societies?
Let me start with the matter of integration: integration does not happen in segregated environments. When people are free to move in and out and among society freely, families integrate over the course of roughly three generations. Put another way, allow for 75 years to integrate a wave of immigration. Looking at blacks in the USA, they were not really allowed to begin to integrate until around 1950, which puts us now in the third generation of their internal immigration experience. While not many people are shocked by interracial marriages in 2015, such things were forbidden in 1961, when JFK refused to allow Sammy Davis, Jr. to appear at his inauguration on account of his being married to a white woman.
Muslims in Europe have a difficult time integrating because of how they've largely been confined to ethnic neighborhoods and in the ways that they've faced legislation designed to keep them from participating fully in their host society. When Algeria became independent from France, for example, France then terminated the veterans' benefits and pensions for all Algerians that had served in the French army during WW2, even if those Algerians lived in France and were French citizens. If Muslims have a hard time of integrating in Europe, look to the racism of the powerful before condemning the clannishness of the weak.
But even eliminating those racist laws will not be an immediate panacea. The three-generation process begins at that point. If the USA is any guide, there will be upheavals, riots, assassinations, murders, rapes, and anguished national questions all along the way. Our answer to those questions need not be a "final" answer, as the Germans reached for in the 1940s. It can be the more difficult answer of tolerance and decency.
So, on to terrorism. Here, I would also point a finger at the men in charge of the powerful nations. In the 1950s through the 1980s, NATO nations and nearby neutral European nations had "stay-behind" programs. These were under the umbrella of Operation GLADIO, and these groups were built up to offer partisan resistance to Soviet forces, in the event of a Warsaw Pact overrunning of Western Europe. These groups were made up largely of men that feared Communists most – many former Nazis and fascists either joined or were recruited for GLADIO teams. Once formed, groups like the CIA saw them as assets that could be used to help steer public opinion away from leftist political movements. The GLADIO groups would commit acts of terrorism and the state would then quickly blame Communists for them, causing public outcry – and a shift in electoral preferences. Anti-terror laws in those nations never focused on the actual perpetrators of the terror, but on supposed enemies of the state. While the USSR had its KGB and rather frank matter of dealing with its dissidents, the NATO nations preferred to frame their dissidents or have them die while in police custody.
As the USSR dissolved, the narrative in the West shifted from a question of whether or not it could avoid a clash of civilization with Russia and instead replaced Russia with a notional form of Islam that suited the narrative. The tolerant Islam as practiced by most Muslims around the world had to be discarded in favor of characterizing it as some sort of evil empire that hated the West. "For its freedoms," ironically. Radicals that happened to be Muslim fit the bill nicely. Why no radical Buddhists or Hindus? Such radicals exist, but because they're not in areas of geopolitical importance, the West had no need to rile them up.
Note that, when radical Muslims were busy destroying Russian or Russian-backed forces, they were 100% Official Friends of the West. When Gulbuddin Hekmatyar was blowing up T-72s in and around Kabul, the West praised him as a freedom-loving Mujaheddin. When the deal to build a US-backed pipeline across Afghanistan fell through, he became a dirty rotten terrorist. The plans to kick him and his Taliban out of power in Afghanistan were already underway in 2001 when the events of 11 September happened.
The same can be said for Chechens that want to rip into Russia. Those guys constitute a "moderate opposition group" to Assad in Syria, even though they're foreign fighters that are there to acquire experience, equipment, and allies. They're going to go home to roost in Russia, so the CIA has had no problem providing them with arms, along with the Turks and Saudis. That the Boston Marathon bombers were Chechen has been largely glossed over in the US media, the more to focus on their being aspects of evil Islam. Were we to make the Chechen connection, it would be much harder to use those forces to overthrow Assad in Syria.
Which brings me back to the GLADIO story: the USA and its allies are arming and training the radicals in Syria. Saudi Arabia is full of organizations that exist to radicalize people. We've known about the Saudi radicalization since the 1990s, and the Syrian operation is the latest in a string of operations that saw the USA and its allies arm extremely violent groups in Libya, Afghanistan, Iraq, and Yemen. When violence from those groups arrives in Western nations, how much of that is orchestrated by the state, in order to keep driving the public demand for more limitations on its freedom in the name of national security – which measures serve only to perpetuate the power of those at the top, not to protect the people from the thugs that kill indiscriminately.
By the way, between the invasion of Tibet and Nixon's visit to China, the USA did sponsor radical Buddhists as they committed acts of terror against the Chinese authorities. The USA did so through the CIA and the brother of the Dalai Lama. When Nixon wanted better relations with China, the aid drops to the Tibetan terrorists suddenly stopped. We now see Buddhists popularly as a bunch of vegetarian pacifists, even though there are some Buddhists that would kill their own mothers if it would get them gain in the world. If it ever suits our needs to target Buddhists as a threat to justify authoritarian legislation in the West, the Buddhists will be targeted, make no mistake.
So, in conclusion, people in general want to live in harmony, even if we have different ways of believing. It is our curse to have leaders that use the radicals that will murder to get gain in order to further their own illicit gain. Those radicals have had different ethnic backgrounds and political views, but they are united by their love of murder, making them – and their political masters – the true common enemy of the West.
This entry was posted in World Hellhole Report on 12/22/2015 by deanwebb.
I am of a school of thought that God tries to communicate to man in ways that the man of the day can understand. But, always, is the caveat from God that his ways are not man's ways. His thoughts are not man's thoughts. His view of life and its purpose is not man's view. But none of those things stop God from doing what he can to make man more like him.
And when I say God communicates in ways that man can understand him, it's not that God limits his communications. God's communications take a certain level of preparation in order to understand and to realize that they are, indeed, messages to us from a person that has a great deal to say to us, if we will but receive those messages. And so much of that communication is mathematical.
I'm not speaking of taking numbers of things in scriptures to manipulate them to get deeper meanings. Rather, mathematics is what defines the entire universe. To me, it stands to reason that mathematics defines that which is beyond our universe, as well.
As I read the scriptures, I am fascinated with the statements that things that seem numberless to us have their number known to God. When God says that there is no time in his realm, that he has made worlds without number to us, and that his course is one eternal round, I take notice. To me, they imply of a number system that exists to properly count and manipulate the universes, to sum each beginning and end of a time-space continuum and to connect it to the ones ahead of it and to the ones behind it.
"Ones" is not even the right word to use to describe to us these bounded near-infinitudes. We exist as mortals, with our spirits barely intersecting with the time and space of this universe, completely unable to see curvature of space from our vantage point. Indeed, all that we can conclude from looking up at the stars is that our view is imperfect.
And when we look at a number such as pi, we find that, again, our view is imperfect. We have calculated 13.3 trillion digits or so of that decimal and never does it repeat, terminate, or even show signs of being a random generation. Our efforts to get to the end of that number can only be finite in this time and space that we have. A few hundred digits suffice for even the most sophisticated of our calculations, so we round it off and move on with things. Yet, there it is, its digits continuing on and on. Because we have not found the termination, we say it does not terminate. Yet, we do not know for sure. We can never know for sure because we have no way of viewing what seems to us to be infinite.
And pi is not alone: nature and natural phenomena are constantly described by numbers such as pi. The square root of 2 has been calculated out to 2 trillion places, making it the second-place number for how determined mankind is to get more digits of. The number e has only been calculated to a few billion digits. These numbers seem out of place among a people more comfortable with tapping fingers to get from one to ten. Yet, there they are. Are there operations we do not know and numbers we do not use that cleanly produce neat, exact representations of both those numbers as well as the integers we desperately cling to?
And what of the beginning and end of our time-space continuum? In ten to the tenth power to the fifty-sixth power years, a universe can go from big bang to heat death to quantum tunneling that produces a new universe. While the causality between elements exists from bang to bang, we do not see a way for causality to continue across such events. Time, therefore, exists between the bangs, but not across them. Eternity, therefore, embraces not just two or three generations of time, but all of them. Such a perspective would have a way of numbering all these things, and that way of numbering would be capable of precision beyond our comprehension, because time would not exist for those that are eternal.
So what mathematics would exist for God and those in his realm? What geometries do they comprehend? What operations are necessary for the angels to execute in order to number the generations of time and space and the matter and energy within them through eternity?
I cannot pretend to answer those questions authoritatively, but I can begin to probe in those directions and, in so doing, I find great beauty and wonderment in mathematics, more so than I did before.
This entry was posted in Reason to Live on 12/13/2015 by deanwebb.


The Journal of Thoracic Oncology has an impact factor of 10.336.
Access Journal of Thoracic Oncology via the Journal Search or from the iDiscover record.
"Journal of Paramedic Practice (JPP) is the only monthly peer-reviewed and evidence-based journal for the paramedic profession, providing the latest practical, clinical and professional information for all paramedics, including emergency care practitioners and assistants, medical technicians, critical care paramedics, combat medical technicians, and members of voluntary aid societies. JPP has a team of consultant editors with a strong commitment to paramedic sciences, as well as a prestigious editorial board that represents different strands of the profession.
"JPP will help you update your knowledge in important areas of practice and ultimately deliver the best possible care to your patients.
Now available to the University of Cambridge electronically from volume 7 (2015) to present.
Access Journal of Paramedic Practice via the Journal Search or from the iDiscover record.
New on ejournals@cambridge A-Z: Journal of 3D Printing in Medicine.
"3D printing, or additive manufacturing, is the process of making a 3D object from a digital file. 3D printing has been in use for several years in certain areas such as manufacturing, and the aerospace and automotive industries. Excitingly, 3D printing, and the related field of 3D bioprinting, is now being used in increasingly advanced ways in healthcare, allowing new levels of precision, personalization and cost efficiency.
"Published by Future Medicine, the Journal of 3D Printing in Medicine (ISSN: 2059-4755) is a peer-reviewed, print and electronic journal poised at the brink of an exciting new era in healthcare. Encompassing all aspects of bioprinting and 3D printing of relevance to medicine, the journal provides a forum for research, review and commentary in a fast-moving, inter-disciplinary research area.
Access Journal of 3D Printing in Medicine via the ejournals@cambridge A-Z or at this link.
New on ejournals@cambridge A-Z : TOPICS IN STROKE REHABILITATION.
Now available to the University of Cambridge electronically from 1997 to date.
Access Topics in stroke rehabilitation via the ejournals@cambridge A-Z or at this link.
New on ejournals@cambridge A-Z : journal of heart and lung transportation.
Now available to the University of Cambridge electronically from volume 18 (1999) to present.
Access Journal of heart and lung transplantation via the ejournals@cambridge A-Z or at this link.
New on ejournals@cambridge A-Z : MEDICAL TEACHER.
Now available to the University of Cambridge electronically from volume 19 (1997) to present.
Access Medical Teacher via the ejournals@cambridge A-Z or at this link.


KAKE News Chief Meteorologist Jay Prater will be in Eureka on April 16, from 4-6:30 p.m. at Orscheln's Farm and Home to assist residents in programming weather radios for the storm season.
Weather radios will be available for purchase, or residents can bring their radio to the event to be programmed with the correct frequency. The weather radio runs on batteries and can be programmed to sound an alert for a specific area and specific weather information.


The Belmont race has the nickname of 'The Test of the Champion' and with a good reason. When it happens, there is always a huge amount of buzz around the event but even when it doesn't it is still one of the biggest horse races in the world with many eyes on the Belmont Stakes results. It has been the scene of 13 Triple Crown winners in its time, with the last one being Justify in 2018.
Justify was able to romp home to victory last year and deliver a memorable moment for the race and it will be interesting to see where the Belmont Stakes odds lie when the next race comes to town, and if a Triple Crown winner is still possible.
As with the Preakness Stakes, the only horse that can be automatically entered into the race is any that is still in contention for the Triple Crown, having already won the previous two races, after that, there are only 11 other places available for your Belmont Stakes picks.
The strict selection means only the best horses will be available for Belmont Stakes betting and this will generally be done via career earnings to that point. It's the same method that is used for the Preakness Stakes and with the Kentucky Derby stakes being done in a very similar way.
Due to the three year age limit, that means that many of the Belmont Stakes picks are known already, especially with famous trainers putting their best horses forward. Leading the pack this year is Bob Baffert who is likely to have three horses vying for the win, and possibly the Triple Crown.
They are Improbable and Game Winner, with many people picking one of those to be their winner in the Belmont Stakes betting and Mucho Gusto which is also expected to place very highly in the Belmont race. There is a chance that Baffert will have a 1-2-3 at one point in the Belmont Stakes betting but there will be many others hoping to disturb that.
Vekoma is another horse who looks set to challenge for the favorite tag in the Belmont Stakes odds, as will War of Will who will most likely be one of the most exciting horses in the field. As it has done plenty of times in the past, the Belmont Stakes results winner may well come from outside the list of Belmont Stakes odds favorite.
Instagrand, Gunmetal Gray, Signalman, Tax and Country House are other horses that might just sit outside the list of Belmont Stakes betting favorites but still have a great chance of winning if they can qualify for the race and have strong performances in the other Triple Crown races.
A lot of the Belmont Stakes picks will depend on those races in Louisville and Baltimore, if there is a Triple Crown threat, then it automatically becomes a popular Belmont Stakes betting option and can often mean there is plenty of value in the rest of the field.
The Belmont Stakes is the third and final leg of the Triple Crown tour and it's a time when many horses go for glory before a well-earned rest with many of them having three races in four weeks, with the Preakness Stakes being the week before and the Kentucky Derby being two weeks before that.
The race is the oldest of the three races as it was started well back in 1867 and it is also the longest of the three too, with the race being run over 1.5 miles. Like all three though, it is a Grade I thoroughbred horse race that is open to three-year-olds.
The other two races have nicknames relating to the flowers that are draped over the winner (roses in Kentucky, yellow flowers in Preakness) and Belmont is no different; the name 'The Run For The Carnations' refers to the race along with 'The Test of the Champions'.
It is hosted in Belmont Park in New York and is a very well attended event with a very high TV audience too. The anticipation can be high if the Triple Crown is on, but more often it is not and is still one of the most prestigious races in the world.
The Belmont Stakes odds will often depend on the winner of the previous two races. There are some great websites that will allow you to participate in Belmont Stakes betting on these races to try and win money by picking the next great horse to come out of the Triple Crown races. It's a great challenge and one that many horse racing enthusiasts love.
Of course, you don't have to be a die-hard horse racing fan to pick a winner in these races. There will be many people using sign-up offers to get involved in the Triple Crown, culminating with this great race.
Once you are on your favorite website and have looked up Belmont Stakes predictions, you'll be able to see all the key details to judge who is going to win the race and try to use that knowledge to win some money. Hopefully, whoever wins the race, you are winning alongside them and enjoying the Belmont race as much as the winning trainer, jockey and horse, whoever that might be.


text:
Tina Knowles >
Beyoncé's twins are 'amazing'
By Bang Showbiz in Lifestyle / Showbiz on 29 September 2017
Follow Tina Knowles
Tina Knowles Jay Z Beyonce Knowles
Beyoncé's twins are ''amazing'', according to her mother Tina Knowles, who also claims five-year-old Blue Ivy is ''excited'' to be a big sister.
Beyoncé's twins are ''amazing'', according to her mother Tina Knowles.
The 36-year-old singer gave birth to twins Rumi and Sir - whom she has with her rapper husband Jay-Z - in June this year, and her mother Tina has given fans an update on the tots, dubbing them as ''beautiful and healthy''.
She said: ''They are amazing. They're very young but they like to touch and they're adorable and just beautiful and healthy and I'm just so happy.''
The 63-year-old businesswoman also shared an update on Beyoncé and Jay-Z's five-year-old daughter Blue Ivy, who Tina says is ''doing amazing''.
Speaking to Us Weekly magazine, she said: ''She's doing amazing! She's a big sister and she feeds them and she's excited. And she feels responsible for them being here because she prayed for them.''
The news comes after it was previously reported that the 'Formation' hitmaker had initially been worried Blue Ivy would ''feel left out'' once the twins arrived, but was pleased when she proved to be an ''amazing'' big sister.
A source said: ''Beyoncé has been very busy with the newborns, but she's also been able to relax a bit. It's helped her that Blue has been such an amazing big sister.
''There was no need to worry because Blue is great. She takes her job as a big sister very seriously and helps out a lot.''
It was also previously reported that Beyoncé is ''full of energy'' since becoming a mother of three.
An insider claimed: ''Beyonce is amazing, she is clocking hardly any sleep right now, but she's full of energy and life!
''Most new moms of twins struggle to even function at this stage, but Beyonce is thriving.
''I mean, obviously it helps that she and Jay-Z have nannies and a bunch of staff, but she's still really hands on and she's breastfeeding, which means she's hardly getting a break rest wise - but then, Beyonce has always functioned best on less sleep than most of us mere mortals!''
Tina Knowles breaks silence on ex-husband Mathew Knowles cancer diagnosis
Tina Knowles bonds with Blue Ivy over make up
Tina Knowles put daughters in counselling as kids
Beyoncé's mother 'can't wait' for daughter to give birth
Tina Knowles plays down controversial Instagram post
Tina Knowles Blasts Haters Who Accused Her Of Lying About Beyonce's Bet Awards Dash
Fascinating Fact: 5294689
Beyoncé 'misses' Tina Knowles
Blue Ivy Prompted Her Grandmother, Tina Knowles, To Consider Marriage To Richard Lawson
Beyonce's mother gets married
Beyonce's Mother Weds - Report
Beyoncé hosting private masquerade ball
Celebrities Index: 0 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

redpajama_set_name: RedPajamaCommonCrawl


This tool summarizes published research that tests control of plant pathogens and algae using water treatment technologies.
The goal is to help you make informed decisions by providing access to research data. We do not recommend any specific technologies or dosage rates.
Water treatment alone is not likely to control pathogens and algae. Take an integrated approach to disease management, including clean plant material, growing media, and containers; and use of fungicides or biocontrol agents. Avoid overwatering because this creates conditions favorable to many diseases and algae.
The use of trade names in this grower tool is solely for the purpose of providing specific information. UF/IFAS does not guarantee or warranty the products named, and references to them in this grower tool does not signify our approval to the exclusion of other products of suitable composition.
Read and follow all relevant EPA and regulatory restrictions, and always follow label instructions and manufacturer recommendations regarding safe practices for workers, the crop, and the environment. Label information supersedes all other sources of information. Phytotoxicity is likely with water treatment technologies with sufficient dose, and not all crops or pathogens have been tested. Always test any product on a small group of plants for phytotoxicity and efficacy before applying to the entire crop.


text:
Q: Trouble Compiling Rcpp I'm having some trouble installing Rcpp for R 3.2.2 on a CentOS 6.5 box. I've found answers that didn't really help both here on StackOverflow and other forums that don't seem to offer much in terms of a solution to this problem. If I attempt to install from within R or from command line with R CMD INSTALL I'm greeted by similar errors ultimately that Rcpp couldn't be installed with the final error make: *** [Date.o] Error 1  and the line/error previous to that being /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/exception:35: error: expected declaration before end of line.
Below is my attempt at installing via R CMD INSTALL Rcpp_0.12.1.tar.gz after grabbing the tarball from https://cran.rstudio.com/src/contrib/.
$ sudo R CMD INSTALL Rcpp_0.12.1.tar.gz
* installing to library '/usr/lib64/R/library'
* installing *source* package 'Rcpp' ...
** package 'Rcpp' successfully unpacked and MD5 sums checked
** libs
g++ -m64 -I/usr/include/R -DNDEBUG -I../inst/include/ -I/usr/local/include    -fpic  -O2 -g -pipe -Wall -Wp,-D_FORTIFY_SOURCE=2 -fexceptions -fstack-protector --param=ssp-buffer-size=4 -m64 -mtune=generic  -c Date.cpp -o Date.o
In file included from ../inst/include/Rcpp/platform/compiler.h:100,
                 from ../inst/include/Rcpp/r/headers.h:48,
                 from ../inst/include/RcppCommon.h:29,
                 from ../inst/include/Rcpp.h:27,
                 from Date.cpp:31:
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/cmath:43:28: error: bits/c++config.h: No such file or directory
In file included from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/stl_tree.h:63,
                 from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/map:60,
                 from ../inst/include/Rcpp/platform/compiler.h:176,
                 from ../inst/include/Rcpp/r/headers.h:48,
                 from ../inst/include/RcppCommon.h:29,
                 from ../inst/include/Rcpp.h:27,
                 from Date.cpp:31:
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/allocator.h:48:31: error: bits/c++allocator.h: No such file or directory
In file included from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ios:42,
                 from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ostream:40,
                 from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/iterator:65,
                 from ../inst/include/RcppCommon.h:49,
                 from ../inst/include/Rcpp.h:27,
                 from Date.cpp:31:
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/localefwd.h:42:76: error: bits/c++locale.h: No such file or directory
In file included from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/ios_base.h:41,
                 from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ios:43,
                 from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ostream:40,
                 from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/iterator:65,
                 from ../inst/include/RcppCommon.h:49,
                 from ../inst/include/Rcpp.h:27,
                 from Date.cpp:31:
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/atomicity.h:34:23: error: bits/gthr.h: No such file or directory
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/atomicity.h:35:30: error: bits/atomic_word.h: No such file or directory
In file included from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/basic_ios.h:39,
                 from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ios:45,
                 from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ostream:40,
                 from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/iterator:65,
                 from ../inst/include/RcppCommon.h:49,
                 from ../inst/include/Rcpp.h:27,
                 from Date.cpp:31:
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/locale_facets.h:43:30: error: bits/ctype_base.h: No such file or directory
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/locale_facets.h:1510:31: error: bits/ctype_inline.h: No such file or directory
In file included from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/cmath:44,
                 from ../inst/include/Rcpp/platform/compiler.h:100,
                 from ../inst/include/Rcpp/r/headers.h:48,
                 from ../inst/include/RcppCommon.h:29,
                 from ../inst/include/Rcpp.h:27,
                 from Date.cpp:31:
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:69: error: expected constructor, destructor, or type conversion before '(' token
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:74: error: '_GLIBCXX_END_NAMESPACE' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:87: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:110: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:125: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:145: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:152: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:159: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:166: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:198: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:205: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:212: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:219: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:226: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:233: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:240: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:247: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:265: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:272: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:279: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:296: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:310: error: '__gnu_cxx' was not declared in this scope
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:311: error: template argument 1 is invalid
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:355: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:378: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:385: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:392: error: '__true_type' does not name a type
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/bits/cpp_type_traits.h:417: error: '_GLIBCXX_END_NAMESPACE' does not name a type
In file included from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/cmath:45,
                 from ../inst/include/Rcpp/platform/compiler.h:100,
                 from ../inst/include/Rcpp/r/headers.h:48,
                 from ../inst/include/RcppCommon.h:29,
                 from ../inst/include/Rcpp.h:27,
                 from Date.cpp:31:
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:45: error: '__enable_if' is not a template
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:64: error: '__is_integer' is not a member of 'std'
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:64: error: '__is_integer' is not a member of 'std'
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:64: error: template argument 1 is invalid
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:64: error: typedef name may not be a nested-name-specifier
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:64: error: expected ';' before '>' token
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:67: error: '__if_type' has not been declared
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:107: error: '__is_integer' is not a member of 'std'
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:107: error: '__is_integer' is not a member of 'std'
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:107: error: template argument 1 is invalid
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:107: error: typedef name may not be a nested-name-specifier
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:107: error: expected ';' before '>' token
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:110: error: '__if_type' has not been declared
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:158: error: '__is_integer' is not a member of 'std'
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:158: error: expected primary-expression before '>' token
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:158: error: expected constructor, destructor, or type conversion before '>' token
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ext/type_traits.h:163: error: '__promote' is not a template
In file included from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/cmath:46,
                 from ../inst/include/Rcpp/platform/compiler.h:100,
                 from ../inst/include/Rcpp/r/headers.h:48,
                 from ../inst/include/RcppCommon.h:29,
                 from ../inst/include/Rcpp.h:27,
                 from Date.cpp:31:
/usr/include/math.h:30: error: expected constructor, destructor, or type conversion before 'extern'
In file included from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ios:40,
                 from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/ostream:40,
                 from /usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/iterator:65,
                 from ../inst/include/RcppCommon.h:49,
                 from ../inst/include/Rcpp.h:27,
                 from Date.cpp:31:
/usr/lib/gcc/x86_64-redhat-linux/4.4.7/../../../../include/c++/4.4.7/exception:35: error: expected declaration before end of line
make: *** [Date.o] Error 1
ERROR: compilation failed for package 'Rcpp'
* removing '/usr/lib64/R/library/Rcpp'

Other Things I've Tried

*

*Verified that gcc.x86_64, gcc-c++.x86_64, and gcc-gfortran.x86_64 are installed

*Verified that make and automake are installed

A: As pointed out in the comments above the trick was using a new version of the compiler via an SCL.
The steps below are adapted from this page on Ask Xmodulo.
$ sudo wget http://people.centos.org/tru/devtools-1.1/devtools-1.1.repo -P /etc/yum.repos.d
$ sudo sh -c 'echo "enabled=1" >> /etc/yum.repos.d/devtools-1.1.repo'

On RHEL6 ayou may need to update the .repo file that got installed to manually set the baseurl to http://people.centos.org/tru/devtools-1.1/6/$basearch/RPMS. From there:
$ sudo yum install devtoolset-1.1

To install system wide R libraries you need to run it as root so doing scl enable devtoolset-1.1 bash and then running sudo R will run the application but without the SCL enabled. So instead:
$ sudo scl enable devtoolset-1.1 bash

That will start a bash shell as root with the SCL enabled. Finally you can install the library with:
# R CMD INSTALL Rcpp_0.12.1.tar.gz

redpajama_set_name: RedPajamaStackExchange


text:
Stories from Thursday, November 11, 2010
Book shares memories of WWII and life (Local News ~ 11/11/10)
As a veteran of World War II, Otis Book of Piggott has a wealth of experiences and recollections from one of the most pivotal events in not only American history, but that of the entire world. "I'm proud to have done my part," Book said. "There were some good times and there were some things you hope to never see again. I wouldn't want to go through it again, but if the cause was there, I'd go again tomorrow if I could still soldier. We had to win that war. There wasn't any other choice."...
School eyes future needs (Local News ~ 11/11/10)
The Rector School District is continuing to look to the future. During Monday night's meeting of the Rector School Board, the decision was made to continue utilizing the services of Warner Concepts in preparing the district's state-required Master Plan. Schools are required to produce a Master Plan, detailing a projected enrollment and facility status for a period of 10 years...
Morris excited about Rector concert, helping others (Local News ~ 11/11/10)
In his career, Gary Morris has commanded the attentions of countless audiences on stages across the globe. On Dec. 10, the beloved icon of country and gospel music, stage and screen will perform a very special concert in Rector with all proceeds of the event going to the Rector High School Helping Hands Foundation...
Bringing a classic to life (Local News ~ 11/11/10)
Hadleigh Watson (left) as White Rabbit, Sydney Simmons as Mad Hatter and Ashley Williams as Alice reflect on the fact that the White Rabbit has said she's late 354 times. Audience members were treated to a glimpse into another world during the RHA Drama Department's Nov. 6 production of "Alice in Wonderland"...
Ruby Janice Lee (Obituary ~ 11/11/10)
Ruby Janice Lee, 82, of Marmaduke passed away Monday, Nov. 8, 2010, at St. Bernards Regional Medical Center in Jonesboro. Ruby was born Sept. 23, 1928, to the late Earl and Iva (Jones) Annis. She was survived by her husband, Monroe (Jack) Lee; one son,...
Irene Cook (Obituary ~ 11/11/10)
Irene Cook, 84, of Rector passed away Friday, Nov. 5, 2010, at the Arkansas Methodist Medical Center in Paragould. She was born Nov. 23, 1925, to the late Willie and Ozolia (Oliver) Geausaway in Clay County. Preceding her in death were her parents; her husband, Merrill Cook; a daughter, Marlene Cook, and a son, Larry Cook...
I'm proud to be a veteran (Column ~ 11/11/10)
Like millions of my generation, I followed the call sent forth from President Roosevelt and the 76th Congress who declared war upon the Japanese Empire after its "day of infamy" in 1941. I was proud then and I have been proud every day of my life since I joined the Navy. ...
God bless our troops (Column ~ 11/11/10)
I didn't hear the political candidates mention the military during their non-stop campaigns that flooded the airways. And kept my phone ringing off the wall. But while the rhetoric was going on, our men kept fighting in Afghanistan. I certainly identify with those men, but especially with their families back at home, waiting...
Board examines test scores, possibility of construction (Local News ~ 11/11/10)
Standardized test scores continue to be an area of discussion for the Piggott School Board. During Monday night's meeting, Board members heard a report from district testing coordinator Barbara Batey offering a complete breakdown of scores received by students a year ago. According to Batey, the importance of reviewing the scores is to give the district an idea of which area students are having difficulties, as well as determining their strengths...
Mohawks honor seniors, blast Corning (High School Sports ~ 11/11/10)
The Mohawks had the hammer down Thursday night, cruising to a 44-0 victory over the visiting Corning Bobcats in Piggott. The Senior Night festivities prior to the game had not only the family members and friends gathered emotionally charged, but also the players on the field, as the Mohawks played the game of football with an unrivaled fervor, imposing their will upon their outmatched county rivals...
Charles Winston Speer (Obituary ~ 11/11/10)
Charles Winston Speer, 77, of Piggott died Monday, Nov. 1, 2010, at the General Baptist Nursing Center in Campbell, Mo. Charles was born in Rector on May 3, 1933, to the late Archie Woodrow and Reba Hessie (Helms) Speer. He was married Feb. 22, 1956, in Hernando, Miss., to Bonnie R. Williams. Four children were born to this union...
Flora Read (Obituary ~ 11/11/10)
Flora Read, 99, of McDougal, passed away Sunday, Nov. 7, 2010, at the Piggott Community Hospital in Piggott. She was born Oct. 11, 1911, and was the daughter of the late Charlie and Angie Clemons Easley. She was united in marriage to Raymond Read on Feb. 20, 1929. He preceded her in death in 1974. She was also preceded in death by four children, Charles Read, Loretta Read, Bobby Read and Jerry Read; daughter-in-law, Letha Read, and son-in-law, Winston Johnson...
Pagene Cook (Obituary ~ 11/11/10)
Pagene Cook, 80, of Piggott, passed away, Friday, Nov. 5, 2010, at the Piggott Community Hospital in Piggott. She was born Jan. 9, 1930, and was the daughter of the late Claude Otis and Vera Mae (Braden) Montgomery. She was united in marriage to George Cook on April 16, 1953. He preceded her in death on April 2, 1993. She also was preceded in death by two brothers, Claude Montgomery Jr. and Donald Montgomery, and three sisters, Twyla Baker, Alice Morrow and Elaine Bomar...
Pansy Elena Gross (Obituary ~ 11/11/10)
Pansy Elena Gross, 89, of Piggott, passed away Sunday, Nov. 7, 2010, at Murphy Health and Rehab, where she resided for the past six years. She was born March 20, 1921, and was the daughter of the late Luther and Ada (Neeley) Nettles. She was married to Frank Gross on July 22, 1939. Frank, one daughter, Norma, and two sisters, Elvera Smith and Elvia Permenter, preceded her in death...
Jerry Holifield (Obituary ~ 11/11/10)
Jerry Holifield, 81, of Paragould, passed away Saturday, Nov. 6, 2010, at Twin Rivers Regional Medical Center in Kennett. He was born Sept. 29, 1929, at Piggott, and was the son of the late James Lloyd Holifield and Ora Bell Busby Niemeyer. He is survived by his son, Todd Holifield, of Louisville, Ky., and many other relatives and friends...
Marshall Edward Drake (Obituary ~ 11/11/10)
Marshall Edward Drake, 78, of Greenway was pronounced dead at his home Thursday, Oct. 28, 2010. Marshall was one of eight children born to the late Robert C. and Mildred "Luna" Drake. He was married to Ruth Evelyn McClure on May 10, 1955. She preceded him in death Feb. 7, 2007...
First Baptist Church has a mission (Local News ~ 11/11/10)
The First Baptist Church Mission House in Piggott provides a needed community service. According to Josie Brandon, mission director, 57 families were served at the Mission House during October. Who are the people whose needs are met at the Mission? A single man needs a suit for a special occasion. ...


We scoured all of Potomac to find the best Plumbers. Below is a full list of the services we offer in the Potomac area, as well as a list of cities where we provide home repair services.
Not Looking for Plumbing Service Contractors in Potomac, DC?


Opt in and stake £5 on Vampire Princess of Darkness™ or Stars Ablaze, and enjoy this super offer of 25 Free Spins.
Stars Ablaze is a 5 Reels and 5 Paylines with an opportunity to cash out 7500.00.
Super Sunday takes place every Sunday (duh) so make sure you come back each week and don't miss out.
Race thru the winter with 100+ cash prizes and free spins to be won!
Enter the Golden Palace Casino Race Thru the Winter promotion and feel the heat as you race towards €3,500 in CASH prizes and thousands of Free Spins.
There are four races, one each week over four weeks, each with its own leaderboard.
Every week, the top 20 players with the highest wagering on the select games will win prizes.
TO ENTER Make a deposit of $20 or more with the deposit code of the week. Play the game of the week and wager as much as you can. Track your progress and check your position daily on the leaderboard.
The promotional period runs from 3 January 2019 (00:01 GMT) until 30 January 2019 (23:59 GMT).
Have a very, merry countdown to Christmas with a snowstorm of up to 1,000,000 bonus spins at casino.com!
More infoShake your tinsel and bounce your baubles – casino.com is giving away up to 1 MILLION SPINS every day in our Christmas countdown (seriously)!
The promotion period is from 00:01 Saturday 01 December – 23:59 (GMT) Tuesday 25 December 2018.
Slots Heaven Casino could be filling up your stocking with up to $100,000 in bonuses over the next three weeks!
Sounds elf-ing good, right? Opt in at Slots Heaven and Wager $20+ on one of the selected games. You'll get a ticket into the weekly draw for each wager!
Take a peek at Slots Heaven to see how much you can grab!


The mission of Art Matènwa is to foster the artists' determination to survive creatively - through art, education and economic security.
Art Matènwa is a long-time collaboration between Cape Cod and Matènwa artists, teachers and students.
Support an artistic/economic development project for Matènwa women and mothers.
Facilitate a cultural exchange between students and teachers at Nauset Regional High School and the Matènwa community, now in its 16th year.
Contribute to village improvement projects such as home and road repair, food gardens, and protection against domestic violence for women and children.
Together we experience and learn from the global conditions and variables that directly affect the art center's economic success. We learn to think beyond the immediate toward the balancing of a future that sustains their business as well as their message.
Our promise is to keep working together to create a stable economic ground.
This has been for all of us, a mutual learning curve. What started out as a modest experiment by a handful of American and Haitian women has opened doors to expansion, ideas, and challenges none of us could ever have foreseen. Life for the artists and their families has changed for the better. They are proud of their creative skills as well as their ability to keep their families healthy and their children in school.
The artists as a group have become a confident, respected voice in the community. They participate in town-wide decisions. Some volunteer to make free meals for children at the school. Recently they've developed public performances addressing issues from condom use to domestic abuse.
After the earthquake of 2010, the artists banded together to rebuild their damaged homes with donations from friends and fans on Cape Cod. The project helped build or repair 42 homes, employing local masons, drivers, and metalworkers and reaching far into neighboring communities.


The game of Omaha Poker is quite similar to the popular game of Texas Hold 'Em Poker and in this poker variant all players sat around the poker table are dealt four cards and are then tasked with making the best ranked poker hand using exactly two of them, plus exactly three of the five community cards that have been dealt out by the Dealer into the center of the poker table.
The game is quite tactical and very strategic and many poker players prefer this game over any other. Keep on reading to find out much more about this great Poker variant and where you can play it online.
Above you can see an image of the real money Omaha Poker table at InterPoker, to view what it looks like in full size simply give the image a click.
If you have never played Omaha Poker before and are seeking a great online poker site at which to try it out then don't forget that our fully approved Poker site that is Party Poker have plenty of real money and free to play tables available 24 hours a day.
On the left hand side you can see one of their Omaha Poker games in full flow, to view it in full size mode simply give the image a click.
The game of Omaha Poker is played with all players taking it in turn to be the Dealer, on online tables the current dealer will usually have some form of marker against their name to indicate that they are the current Dealer. Once each game has finished then it is the turn of the person sat on the left of the current Dealer to become the new Dealer.
Before a game begins and any of the cards are dealt, the Omaha rules state that players must place what is called a Small and Big Blind Bet into the center of the Omaha Poker table. The player who happens to be sitting to the left of the Dealer has to place what is called the Small Blind Bet and then next, the player to his or her left must double the Small Blind Bet and place this wager into the pot this wager is called the Big Blind Bet.
The Dealer will then deal out to each player in the game the Pocket cards these are four cards dealt face down to every player.
What follows next is the first Betting Round, the player who is sat to the left of the player who bet the Big Blind is tasked with opening this betting round and then this betting will continue clockwise until every other player sat at the table has made their betting choice, they can opt to either fold their cards, call or raise the Big Blind Bet.
The Dealer, once the above betting moves have all been made by the players, has to deal out the Flop Cards, and these are simply three cards, face up, placed at the center of the table. The Flop cards are also known as community cards and all of the players are free to use them to help them complete their poker hand.
Next follows the second betting round and this follows the same structure as first, but the betting starts from the player seated to the left of the Dealer, once all betting decisions have been made the Dealer will deal out into the center of the poker table what is termed the Turn Card, which is simply the fourth community card.
What follows is another round of betting and then the Dealer has to deal the fifth and final community card, this is known as the the River Card and this is followed by a final betting round.
Next is the final phase of the game of Omaha Poker known as the Showdown, and this is where each player shows his best five card hand. The player with the best hand using exactly two of their pocket cards, plus exactly three of the five community cards will win the entire pot.
There is another variant of Omaha Poker which is known as High Low Omaha, this game has the same game play structure and better rounds, but at the showdown part of the game the pot is split equally between the two hands that have, 1. The lowest ranked poker hand and, 2. The highest ranked poker hand.


SCA produces paper, pulp and wood products and it has been buying timber from the Baltic countries for many years and it was suggested that this next step was logical.
The assets comprise 7600 hectares of productive forest land, 2000 hectares of farmland and 800 hectares of other land. The standing timber volume amounts to one million cubic metres.
"We have been in the Baltic states for a long time as a buyer of timber," Jonas Mårtensson, of President of Forests at SCA said.


I came across this cute explanation by Jack Ashby of when to use "bear" vs. "bare" and thought I'd share. Enjoy.
This entry was posted on June 21, 2013 by Maryann Hammers in copyedit, editing, grammar, language usage, words, writing and tagged American black bear, Bear.


This guide will cover how to: download the .NET SDK and Microsoft Visual Studio, create and configure a C# project, and create and send a document package (transaction in the new UI).
Before you can write your code, you will need to set up your environment to use the .NET SDK.
Before you can use the .NET SDK, you will need to download it. Below is the link where you can download the .NET SDK.
This guide uses Microsoft Visual Studio 2017. You can use something else, but everything in this guide will be described using Visual Studio. Below is a link to download where you can download it.
Now that you have the necessary tools, you can go ahead and get started.
After opening Visual Studio, go to File -> New -> Project and choose Get Started-> Console App from the templates. Give your project a name. For example, "CreateAndSendPackage".
Select OK. You will now see your solution/project in the Solution Explorer.
Next, add the .NET SDK as a reference by right clicking on References, in your project, in the Solutions Explorer. Choose "Add Reference…" In the dialog that pops up, choose "Browse", select the "Browse…" button at the bottom, navigate to where you unzipped the .NET SDK, select the three .dll files, and choose Add.
Finally, right click on your project, select Add -> New Item…, select the Code section in the pop-up, choose Code File, name the file whatever you want (e.g. "CreateAndSendPackge.cs"), and select Add.
You will now see this file in your project in the Solution Explorer.
This segment of the guide will breakdown the code section by section. You can get the complete sample code from the Developer Community Code Share, here.
The first few lines define the libraries you will use.
The next few lines define your connection settings for OneSpan Sign. Be sure to replace YOUR_API_KEY with your API key. You can find this value by logging into OneSpan Sign and going to the ACCOUNT tab.
The first thing you do is connect to the OneSpan Sign client using the API URL and API key you defined above.
In the next line, you create a FileStream and read in the file you are wanting to upload with your package. Make sure you replace the placeholder text with the location of your PDF file.
Next, the package is created.
Then, the signers are added to the package.
Next, the document is added, including signature boxes for required signers.
With the package completely defined, you now build the package and send it.
Execute this code by selecting Start from the toolbar. After doing this, you should be able to log into OneSpan Sign account and view the package you just created.


text:
More transparency needed in Rocky Mountian Trench logging plans
VICTORIA – McBride Forest Industries and the Headwaters Forest District should provide more detailed information in logging plans for the Rocky Mountain Trench, the Forest Practices Board reported today.
The board investigated a complaint by the Fraser Headwaters Alliance. The complainant was primarily concerned about the licensee's ability to meet the visual quality objectives (VQOs) in the Robson Valley Land and Resource Management Plan (LRMP). The complainant objected to the district's approval of the licensee's logging plan, which allowed an exemption from the VQO standards if the licensee believed it would be difficult to meet them when salvaging beetle-infested trees.
The board concluded that the actions of the licensee and the district, in trying to address the mountain pine beetle outbreak in the area, did not result in any damage to forest resources. The board found one amendment to the logging plan did not meet legal requirements, as it showed only large areas within which logging would take place, rather than specific cutblock boundaries as required by legislation. The board also found the district manager did not have the authority to approve the exemption from VQO standards in the plan, at the time the approval was granted.
"This logging occurred in the context of a severe mountain pine beetle infestation, and the licensee anticipated difficulties in maintaining required standards for forest practices under those conditions," said board chair Bruce Fraser. "While the board recognizes the unique challenges posed by the beetle epidemic, we believe the Forest and Range Practices Act provides sufficient flexibility for licensees to meet those challenges within the law."
The board recommends the licensee give the public an opportunity to review the large undefined logging zones when preparing its forest stewardship plan (FSP) for the area subject to complaint. This plan must be approved by December 31, 2006, under current timelines.
"In our recent special report, the board recommended that FSPs need to provide more details on specific logging locations within the area covered by the plan," said Fraser. "In this case, we hope the licensee will provide sufficient geographic detail to allow for effective public review of the FSP in question."
Other findings of the investigation include:
With a few exceptions, the licensee is meeting the VQOs set by the Robson Valley LRMP.
Logging in a recreation and conservation area complied with both the LRMP and provincial legislation.
Logging and road-building near a fish stream did not comply with legal requirements, but these minor contraventions had no significant impacts on forest resources.
The Forest Practices Board is an independent public watchdog that reports to the public about compliance with the Forest and Range Practices Act (FRPA) and the achievement of its intent. The board's main roles under FRPA are:
Auditing forest practices of government and licence holders on public lands.
Auditing government enforcement of FRPA .
Investigating public complaints.
Undertaking special investigations of forestry issues.
Participating in administrative appeals.
Providing reports on board activities, findings and recommendations.
Consistency of Logging with the Robson Valley LRMP
British Columbia has about 40 different species of native trees.


text:
Q: Using decode_predictions() from the vgg16 model I'm trying to attach a probability value to my bounding boxes. I am currently tracking two objects on the same image, and I transfer learn the vgg16 model using the Keras functional API.
  vgg = VGG16(weights="imagenet", include_top=False, input_tensor=Input(shape=(224,224,3)))
    vgg.trainable = False

    def output_boundingbox_layer(name):
        flatten_out = Flatten()(vgg.output)

        bbox = Dense(512,activation="relu")(flatten_out)
        bbox = Dense(256,activation="relu")(bbox)
        bbox = Dense(128,activation="relu")(bbox)
        bbox = Dense(64,activation="relu")(bbox)
        bbox = Dense(32,activation="relu")(bbox)
        #Dense layer with 4 nodes because there are 4 coordinates to consider,
        #xmin, ymin, xmax, ymax --> the bounding box
        bbox = Dense(4, activation="sigmoid", name = name)(bbox)
        return bbox

model=Model(inputs = vgg.input, outputs=(bboxlayer, bboxlayer_2)
model.compile(loss=losses, optimizer=Adam(), metrics=["accuracy"], loss_weights=lossWeights)

    history = model.fit(
        train_images,
        trainTargets,
        validation_data=(
            test_images,
            testTargets
            ),
        batch_size=32,
        epochs=100,
        verbose=1
        )

I did not include the remaining dictionaries where I define the loss functions and loss weights as well as assigning the various test_train_split() arrays to keep this question relatively short. I'm predicting frame by frame on a test video and it does a pretty good job from a qualitative observation, however I would like to attach a probability value. I'm having troubles getting that information. Using decode_predictions() I get the following output:
#Prediction results
[array([[0.4525235 , 0.20031905, 0.6131844 , 0.46470878]], dtype=float32), array([[0.4420103 , 0.09556548, 0.533233  , 0.23276633]], dtype=float32)]

#Traceback from decode_prediction()
in decode_predictions
    if len(preds.shape) != 2 or preds.shape[1] != 1000:

AttributeError: 'list' object has no attribute 'shape'

Even when I try indexing the list to just one array I still get a similar error. I was thinking about training a separate softmax network but that just seems excessive to load two models simultaneously.

A: Maybe try stacking your predictions, since you have a list of arrays:
preds = tf.stack(preds) # or np.stack


text:
Engineered Bicycles Gezel
It's getting harder and harder for the bigger bike manufacturers to keep up with the market, as we expect more from our bikes. Over the last few years, we've demonstrated that we don't just want bikes that do one thing. We want to take our bikes further than they've ever been before.
We want to ride further than the end of the road, and we want them to be comfortable in all sorts of weather. Call them 'gravel grinders', 'all-road' bikes, or whatever you will, they just have to be practical for the everyday and adventurous rider — like Bristol's Engineered Bikes and their Gezel.
At the heart of the Gezel is a Dedacciai Zero XL frame whose geometry and features can be modified to your specifications. For example, Engineered Bikes are developing a Gezel at the moment that accepts interchangeable rear dropouts that can be swapped between a QR and thru-axle rear wheel.
The front of the frame is a 44mm head tube and a press-fit headset, through which runs a carbon fork. While the standard frame has external cable routing, to minimise the ingress of moisture, internal routing can be requested — as can variations on the paint and design.
32c tyres fit fine, or 28c tyres with mudguards, making it a steadfast bike in all conditions. Testing was carried out on the Flandrien cobblestones, where it was passed with flying colours. The Gezel is disc brake-specific, mounted on the chain stay for ultimate harmony when fitting racks and fenders.
It can be built around electronic systems with internal cables, as a mechanical setup, or both, as required. It can even accommodate an Alfine configuration, if you're so inclined. With race-inspired measurements tweaked for all-day comfort, this could be the only bike you'll ever need.
Engineered Bicycles designed the Gezel in Bristol for real-world riding, but the frames are made in Italy by master frame builders and sent back to Bristol for finishing. Translated from Old Dutch, Gezel means 'journeyman' or 'companion' — an appropriate title.
Special thanks to James King for the photos.
Engineered Bicycles Website | Facebook | Instagram
Filed Under Road Bicycles TAGGED United Kingdom Sep 21, 2015 Adam
Review: Levi's® Commuter™ Backpack


text:
Drew Angerer/Getty Images News/Getty Images
The Funniest First Presidential Debate Tweets Made Digs At One Candidate
by Jo Yurcaba
The first presidential debate at Hofstra University was the first time that people had any opportunity to see Donald Trump in action against former Secretary of State Hillary Clinton. Clinton, who has years of policy experience and knowledge, isn't someone that most people would want to go head to head with in a debate. And the funniest first presidential debate tweets noted that while also making fun of Trump's serious lack of qualifications.
Common themes of tweets on Monday night were either making fun of Trump, calling Clinton terrible names, or talking about how important alcohol will be for those watching the debate.
The election is essentially tied between Trump and Clinton, so the debates collectively could greatly affect who wins those last few percentage points before the Nov. 8 election day. According to CNN, Clinton prepped by doing mock debates with former aide, while Trump watched videos of Clinton while refraining from doing any "intense" preparation such as mock debates.
But, some tweeters didn't take aim at either of the candidates. Instead, some decided that the moderator, Holt, wasn't doing a very great job of moderating when Trump was badgering Clinton about President Barack Obama's policies.
Others pointed out sexism during the debate (because women are supposed to control all of their husbands' actions).
And of course, there for a few Game of Thrones' references:
Even the third-party candidates chimed in occasionally, because even though they weren't invited, they couldn't say out of the action.
Of course, many people didn't just make fun of Trump and Clinton, they also made fun of each of the candidates specific styles of speaking and quirks. For example, Trump repeatedly referred to cybersecurity as just "cyber," and it was at times unclear if he was talking about security or cyber warfare.
But one of the best moments of the night came when Trump said he has a better temperament than Clinton does. Not only did the audience laugh out loud (which isn't allowed, because the moderators wanted to make sure the candidates could speak as much as possible and without interruption), but people on Twitter just couldn't even deal with it.
This was Clinton's response, because how else do you respond to that?
And the Twitter responses were gold:
I don't know what just happened, but I need a Tempur-Pedic right now. Tweets from the debate made it clear that Trump was all over the place, and Clinton just had to maintain her composure to easily make herself seem like the more prepared and qualified candidate.
See AllTryingBirthAfter
See AllBabyToddlerLittle KidBig Kid
See AllSex & RelationshipsWellnessStyle
See AllFoodHomeEntertainmentPoliticsShopping
AboutTermsPrivacyNewsletterArchiveAdvertiseMastheadEditorial Standards


text:
Kite Pharma is an American biotechnology company that develops cancer immunotherapy products, with a primary focus on genetically engineered autologous CAR T cell therapy, a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009 and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.

History
The company was founded in 2009 by Arie Belldegrun, an Israeli-American oncologist, who served as the company's chairman, president and chief executive officer. Belldegrun had a co-founder in Joshua Kazam, who took on the role of Director.

On August 28, 2017, Gilead Sciences announced that it would acquire Kite Pharma for $11.9 billion in an all-cash deal, a 29% premium on the share price. Gilead made the purchase in large part to bolster sales in the face of the company's declining hepatitis C franchise revenues, a result of declining patient numbers as they were cured, as Kite's sales were anticipated to reach $2 billion per annum. The acquisition was completed in October 2017, when Kite Pharma's Yescarta became the first CAR-T therapy approved by the FDA for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. This form of immunotherapy was originally developed by the U.S. National Cancer Institute and the company pays the government to support continuing research.

In 2017, MIT Technology Review ranked Kite Pharma 7th in its annual list of the preceding year's 50 Smartest Companies.

Lead product
Axicabtagene ciloleucel (KTE-C19, ZUMA-3, YESCARTA) was an investigational therapy (for the treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL)) in which a patient's T cells were genetically modified to express a chimeric antigen receptor designed to target the antigen CD19, a protein expressed on the cell surface of B-cell lymphomas and leukemias. It garnered a US FDA Breakthrough Therapy Designation (Dec 2015) for the treatment of patients with refractory diffuse large B cell lymphoma (DLBCL), primary mediastinal B cell lymphoma (PMBCL), and transformed follicular lymphoma (TFL). It was approved for use in the United States under the brand name YESCARTA in October 2017.

Development history

2012
In October, Kite Pharma entered into a Cooperative Research and Development Agreement with the National Cancer Institute (NCI) for the development and commercialization of products for the treatment of multiple cancer indications.

2013
In December, the company announced data in its lead clinical development program with the NCI, demonstrating that Kite's most advanced immunotherapy product candidate – KTE-C19 CAR – can produce robust and durable tumor shrinkage in patients with an aggressive form of non-Hodgkin's lymphoma, known as diffuse large B cell lymphoma (DLBCL). The clinical data were presented at the 55th American Society of Hematology Annual Meeting.

2014
The company announced in March, that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation for the company's proposed therapy for DLBCL.

In June, Kite Pharma entered into an exclusive, worldwide license with the National Institutes of Health (NIH) to certain intellectual property related to TCR-based product candidates that target the NY-ESO-1 antigen for the treatment of cancers expressing NY-ESO-1.

Kite Pharma announced findings from its ongoing clinical trial in August: 12 of 13 evaluable patients with advanced B-cell malignancies had complete remissions (8 patients) or partial remissions (4 patients) resulting in a 92% objective response rate. The results support Kite Pharma's plan to file an Investigational New Drug (IND) application in the fourth quarter of 2014 to initiate a clinical trial of Kite Pharma's lead CAR-based product candidate, KTE-C19, in patients with DLBCL.

2015
In January, Kite Pharma and Amgen entered into a strategic research collaboration and license agreement to develop and commercialize the next generation of novel Chimeric Antigen Receptor (CAR) T cell immunotherapies based on Kite's engineered autologous cell therapy platform and Amgen's extensive array of cancer targets.

Kite Pharma announced in May, that the first patient in its Phase 1/2 clinical trial of KTE-C19 in patients with refractory aggressive Non-Hodgkin's Lymphoma has been treated.

In June, Kite Pharma and bluebird bio, Inc. announced they have entered into a collaboration agreement to co-develop and co-commercialize second generation T cell receptor product candidates directed against the human papillomavirus type 16 E6 onco protein incorporating gene editing and lentiviral technologies.

In July, Kite Pharma and the Leukemia & Lymphoma Society announced that they have entered into a partnership to enhance the development of Kite's lead product candidate, KTE-C19, for the treatment of patients with refractory aggressive Non-Hodgkin's Lymphoma.

In September, Kite Pharma announced that it has expanded its collaboration with the Netherlands Cancer Institute (NKI). Kite and the NKI have entered into an agreement under which Kite will receive from the NKI the exclusive option to license multiple T cell receptor (TCR) gene sequences for the development and commercialization of cancer immunotherapy candidates targeting solid tumors. Kite has also expanded its access to additional resources and research facilities through a master services agreement with the NKI.

In October, Kite Pharma announced that it has entered into an exclusive, worldwide license with the National Institutes of Health (NIH) for intellectual property related to T cell receptor (TCR)-based product candidates directed against MAGE A3 and A3/A6 antigens for the treatment of tumors expressing MAGE, which include lung, pancreatic, gastric, and breast cancers, among others. In the same month, Kite Pharma announced that it has entered into a worldwide research and license agreement with Alpine Immune Sciences (AIS), a privately held biotechnology startup, to discover and develop protein-based immunotherapies targeting the immune synapse to treat cancer. AIS will grant Kite an exclusive license to two programs from its Transmembrane immunomodulatory protein (TIP) technology, which Kite plans to further engineer into chimeric antigen receptor (CAR) and T cell receptor (TCR) product candidates. This collaboration will accelerate Kite's efforts to establish the next generation of engineered T cell therapies specifically designed to overcome the inhibitory mechanisms present in the tumor micro-environment.

In December, Kite Pharma announced that it has initiated a phase 1/2 clinical study of KTE-C19 (ZUMA-3) for the treatment of adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL). KTE-C19 is an investigational therapy in which a patient's T cells are genetically modified to express a chimeric antigen receptor designed to target the antigen CD19, a protein expressed on the cell surface of B-cell lymphomas and leukemia's. In the same month, Kite Pharma and GE Global Research announced they will partner to develop a next-generation, functionally integrated and automated manufacturing system for engineered T-cell therapy. Kite and GE Global Research—GE's centralized R&D hub—said they aim to increase the availability of engineered T-cell therapies by speeding up development of automation technologies that have the potential to lower costs, operate faster, and minimize variability. Also in December, Kite announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation status to the company's lead product candidate, KTE-C19, for the treatment of patients with refractory diffuse large B cell lymphoma (DLBCL), primary mediastinal B cell lymphoma (PMBCL), and transformed follicular lymphoma (TFL).

2016
In January, it was announced that Kite Pharma has entered into a Cooperative Research and Development Agreement (CRADA) with the NCI for the research and clinical development of a fully human anti-CD19 chimeric antigen receptor (CAR) product candidate for the treatment of B-cell lymphomas and leukemia. Moreover, Kite Pharma announced that its European subsidiary has entered into a research and license agreement with Leiden University Medical Center (LUMC) to identify and develop T cell receptor (TCR) product candidates targeting solid tumors that are associated with the human papillomavirus (HPV) type 16 infection.

In March, Kite Pharma has announced that it would be collaborating with Genentech, in order to evaluate the safety and efficacy of two of its novel therapies. The target population for the tests would be patients with non-Hodgkin Lymphoma. The therapies in question, KTE-C19 and atezolizumab, would be tested in combination with each other.

In June, Kite Pharma and Cell Design Labs, Inc. announced a research collaboration and license agreement to develop next generation, precision-controlled chimeric antigen receptor (CAR) product candidates that incorporate Cell Design Labs' molecular "on/off switch" technology. Also in June, Kite Pharma announced that it has entered into a new Cooperative Research and Development Agreement (CRADA) with the Experimental Transplantation and Immunology Branch (ETIB) of the National Cancer Institute (NCI) for the research and clinical development of T-cell receptor (TCR) product candidates directed against human papillomavirus (HPV)-16 E6 and E7 onco-proteins for the treatment of HPV-associated cancers.

In July, Kite Pharma announced that it has entered into an exclusive, worldwide license agreement with The Regents of the University of California, on behalf of the University of California, Los Angeles (UCLA), for technology to advance the development of off-the-shelf allogeneic T-cell therapies from renewable pluripotent stem cells.

In December, Kite Pharma and Vitruvian Networks, Inc., a pioneering cell and gene therapy software and analytics platform company co-founded by GE Ventures and the Mayo Clinic, announced a strategic partnership to create a software solution to support commercial availability of T-cell therapies. Together, the parties will design and develop a platform for patients, physicians and treatment centers that enables commercial-scale ordering, logistics, monitoring and delivery of autologous cell therapies if they are FDA-approved, including axicabtagene ciloleucel (formerly known as KTE-C19), Kite's lead investigational engineered T-cell therapy for aggressive non-Hodgkin lymphoma.

2017
In March, Kite announced results a clinical trial of CAR-T cells in around a hundred people with advanced Non-Hodgkin lymphoma.

In April, Kite has won the 'Clinical Trial Result of the Year' award for its CAR-T trial of Axicabtagene Ciloleucel in patients with Aggressive Non-Hodgkin Lymphoma at the Clinical and Research Excellence Awards. The award recognizes clinical achievements in the pharmaceutical industry and contribution to the advancement of therapies for unmet medical needs.

In August, Kite has filed the first CAR-T candidate in Europe, seeking approval of its axicabtagene ciloleucel (KTE-C19) for two types of non-Hodgkin's lymphoma (NHL).

Business history
In March 2011, Kite Pharma received $15 million in Series A venture cash.

In May 2013, Kite Pharma completed a $35 million financing of Series A preferred stock.

In April 2014, Kite Pharma completed a $50 million mezzanine private financing of convertible notes.

In May 2014, Kite Pharma filed a registration with the SEC for an initial public offering (IPO) of its common stock.

In June 2014, Kite Pharma sold 8,625,000 shares of its common stock in their IPO at $17.00 per share, for gross proceeds of $146.6 million. The company listed on the NASDAQ Global market under the symbol "KITE."

In December 2014, Kite Pharma sold 4,007,750 shares of it common stock in their follow-on offering at $54.00 per share, for gross proceeds of $216.4 million.

In March 2015, Kite Pharma acquired T-Cell Factory (TCF), a privately held biotechnology company based in the Netherlands, for €20 million and renamed it – Kite Pharma EU. Per the deal, Kite Pharma has obtained license agreements with IBA GmbH, Sanquin Blood Supply Foundation and the Netherlands Cancer Institute (NKI), which include the rights to select new intellectual property related to T-cell receptors (TCRs) developed at the NKI. Additionally, the TCF acquisition will allow Kite Pharma to access the European manufacturing facilities, paving way for the company to initiate development programs in the EU and build its presence in the region.

In December 2015, Kite Pharma sold 4,168,750 shares of its common stock in a public offering at $69.00 per share, for gross proceeds of $287.6 million.

In January 2017, Kite Pharma announced that it has partnered with Daiichi Sankyo Co Ltd to develop and commercialize its cancer treatment therapy in Japan, putting the U.S. company in line to receive up to $250 million in payments, of the $250 million, Kite said it would receive $50 million as upfront payment. Also in January, Kite Pharma announced that it had formed a joint venture with Fosun Pharmaceutical to develop and commercialize its cancer treatment in China. Kite Pharma said it would receive an upfront payment of $40 million from the joint venture, funded by Fosun Pharma as well as regulatory and commercial milestones totaling $35 million.

On August 28, 2017, Gilead Sciences announced that it would purchase Kite Pharma for US$11.9 billion in cash ($180.00 per share). The purchase was subsequently completed for the announced price on October 3, 2017.

The company has primary leading manufacturing facilities in El Segundo, CA next to Los Angeles International airport and Amsterdam, Netherlands to support US, Canada, Australia and European markets. Kite is in the process of coordinating additional manufacturing capacity from its recent expansion into Urbana, Maryland facility as of 2023 as a strategic center that could accommodate same-day service to both California and Netherlands manufacturing operations.

In February 2023, the business completed its acquisition of Tmunity Therapeutics

Allogene Therapeutics
Following the sale of Kite to Gilead, Kite's founders and its CMO struck a deal in February 2018 with Pfizer to develop CAR-T therapeutics, leading to the creation of Allogene Therapeutics. The three former Kite executives subsequently hired into Allogene a number of people who left Kite after its sale. The notion behind Allogene was to create a 'next generation CAR-T' which was not tailored to a single individual, as YESCARTA was, but rather could be used in multiple patients, an allogeneic CAR-T. Pfizer received a 25% stake in Allogene and two seats on the company's board, while Allogene received rights to sixteen pre-clinical CAR-T assets and one Phase 1 allogeneic CAR-T clinical asset. Allogene's Series A funding was US$300 million, including Texas Pacific Group, University of California, Two River—and even Gilead as participants, among others. In October 2019, Allogene's initial public offering netted US$324 million and a capital valuation of US$3 billion.

See also
Iovance Biotherapeutics

References

External links
 Kite Pharma - official website

Biotechnology companies established in 2009
Pharmaceutical companies established in 2009
American companies established in 2009
2009 establishments in California
Health care companies based in California
Companies based in Santa Monica, California
Biopharmaceutical companies
Companies formerly listed on the Nasdaq
Gilead Sciences
2014 initial public offerings
2017 mergers and acquisitions


text:
July 19, 2017 July 19, 2017 Hadaway & Hadaway Employment, Health, Law
The NHS is an institution that the British public is very proud of and should be lived up to. Everyone involved from doctors to nurses and other professionals within health care perform a tremendous service looking after and caring for those who are injured or ill. As of this year, in order to improve confidences within NHS, there are new policies and procedures guidelines that support whistleblowers that each National Health Service had to review.
Deliberations were concluded in May of 2016 and the final guidelines were released this year. The new policies were introduced after an intense period of discussions and after reviewing the reluctance of NHS staff to step forward with their concerns regarding the safety of patients and inadequate funding.
Many of the leading healthcare workers have long believed that speaking up had many consequences including:
They worked within a small team and feared the backlash they would get from their colleagues. They were also afraid of losing their jobs if they raised any concerns to their employer. Workers in ancillary and non-clinical positions felt they had fewer options because they did not have access to a prominent group of leaders or a union.
The National Health Service Director for Patient Experience strongly believes that in order to have the safest health system takes listening to their staff and taking action where needed. Should a staff member discover something that is putting patients at risk, they should feel safe in expressing these concerns without repercussions.
The new guidelines have been put in place to create good practices, provide primary care staffers more options in order to share their concerns, and allows employers to handle these concerns correctly. In order to have a safe NHS, there must be open and honest communication in order to routinely learn from their past mistakes. They should take these mistakes and learn how to improve their patients' safety.
Whistleblowing can help point out bad practices going on within an organisation. That said, these claims must be honest because the final outcome could lead to criminal actions against an organisation while unveiling cover-ups that are dangerous and not in the best interests of patients.
In 2014, an independent review board, chaired by Sir Robert Francis, revealed that whistleblowers within NHS were intimidated, bullied, ignored, and, in many cases, fired. During an interview, Sir Francis stated that approximately 30% of those raising concerns felt unsafe after speaking up.
He went on to point out that 18% of staff employees did not trust the system and therefore would not speak up. Another 15% stated they were afraid of being victimised if they were to say anything at all. This climate of fear was created by a number of people losing their jobs because they chose to speak up. These people have lost their jobs, their livelihood, and have found it very difficult to find new employment. Sadly, some cases have felt suicidal tendencies or became seriously ill in the aftermath. Before releasing his report, Sir Francis said nurses, in particular, had raised many concerns regarding intimidation and bullying within NHS Trusts.
A survey conducted in 2013 of 8,262 nurses revealed that 24% had been warned against making any public statements regarding their concerns. Approximately 45% of the participants said their employers took no actions regarding their concerns and 44% were very concerned about suffering from repercussions or being fired. Other threats made them think twice about whistleblowing about dangerous or negligent practices they had witnessed.
Based on the recommendations of Sir Francis's report, the foundation for establishing a new NHS guideline regarding whistleblowing was born. The new policies offer steps to protect the safety of NHS employees who speak up.
Each NHS Trust should appoint a Freedom To Speak Up Guardian. This individual should not be within the chain of command management group. He or she will provide support to staff members who have genuine concerns. There should be further steps taken to prevent inappropriate behaviour including harassment, discrimination, or bullying toward staff members who speak up.
All NHS primary care providers were required to review and update their policies and procedures by March of 2017. The principles of the agreed upon guidelines were then incorporated.
Last year in 2016, Dr. Henrietta Hughes, medical director for NHS England's North Central and East London region, was named National Guardian for Safeguarding of Whistleblowers. Paraphrasing a statement after her appointment, she believed it takes a lot of courage, honesty, and selflessness to be a whistleblower. She also said that no one should ever be afraid to come forward for fear of punishment when speaking up for the safety and care of patients.
Along with her office, their national partners, and anyone who wants to support and protect staff members who speak up will help her drive a new agenda of openness. "Ultimately, these new policy guidelines will make for a safer NHS." Staff members will have a great deal of support and gain confidence in speaking up especially for the public's interest in safety.
The Case Of Dr. Hayley Dare – Feb 11, 2015:
Dr. Dare had a perfect 20-year reputation for helping patients and excellence within her field. Her entire career was damaged when she chose to speak up about concerns for patients' safety to the CEO of the West London Mental Health NHS Trust. Absolutely no one should ever have to go through such a horrific experience like she did.
The NHS Trust spent £130,000 fighting Dare's accusations, even though they understood that her claims were accurate. She was harassed, called "A Very Disturbed Women", bullied, and then fired. After losing her job, based on a legal technicality, the Judge said her disclosure was not made in good faith (which did not exist at the time) and a provision that no longer has to be satisfied. The NHS Trust went after Dr. Dare for £100,000 in court costs.
Things have changed thanks to Sir Francis' report, the creation of the Freedom To Speak Up Guardianship, the network of Freedom to Speak Up Guardians in NHS Trusts, and others who support and protect those who speak up. No one should ever go through this again.
About Sir Robert Francis:
He is a British barrister who specialises in medical law, treatments for mental and medical issues, clinical discipline and negligence. He has chaired various independent investigations.
Employment law NHS


text:
Alberta woman dies in confrontation with police after calling for help
There was a confrontation and one of the responding officers discharged a firearm
Sep. 23, 2019 12:27 p.m.
Police say a woman has died in an encounter between her and officers who went to her home in a county east of Edmonton.
Strathcona RCMP say the woman called for help around 7:30 a.m. on Monday.
They say there was a confrontation and one of the responding officers discharged a firearm.
The woman was seriously injured and taken for treatment, but she died in hospital.
Police say no officers were injured.
The Alberta Serious Incident Response Team is investigating.
READ MORE: B.C. police watchdog to investigate man's head injury during RCMP arrest
UN chief urges action to make Earth carbon neutral by 2050
VIDEO: "How dare you?" Greta Thunberg addresses UN climate summit


In PART TWO of this Holiday special episode NOBODYSMILING.COM's Dondiego joins to discuss: Hiphop flags, corporate interests, sheeple, mass media influence and the monetization of hiphop. Lack of respect of hiphop elders. Fatherless Children and its effect on hiphop music. Hiphop where's your daddy?


Is your child 4 years old before 1st September 2019? If yes, and you require a school place in September 2019, you will need to make an application to the LA for your child by 15th January 2019 at the latest. Please do this online at www.staffordshire.gov.uk/admissions alternatively, contact the School Admissions and Transport Service on 0300 1118007 to make a telephone application.
St Dominic's Catholic Primary School is a Voluntary Aided Catholic Primary School for boys and girls aged 4 to 11 years. The school serves the parishes of The Immaculate Conception and St Dominic's, Stone, Our Lady's Swynnerton and Sacred Heart, Eccleshall. The school has capacity for 210 children on roll.
Evidence of Catholic Baptism or Reception into the Church will be required. For definition of Baptised see the Appendix. Those who face difficulties in producing written evidence of baptism should contact their Parish Priest.
The home address of a pupil is considered to be the permanent residence of a child. The address must be the child's only or main residence. Documentary evidence may be required.
Children must, by law, start school by the beginning of the term after their fifth birthday. A parent may defer a child's entry to the school. Parents may discuss this with the Headteacher.


From a form, how to display/edit an interval value in the db? Year/Month/Day/Hour/Minute/Second needs to be set in this case. The database is Postgres and I made a table named "intervals" which has a column named "interval_values" of type INTERVAL.